{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:10:26Z","timestamp":1785795026481,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Medical Journal Pulmonary and Critical Care Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pccm.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:23:06Z","timestamp":1741609386000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pulmonary embolism prophylaxis and treatment: What's right, what's wrong, and the future"],"prefix":"10.1016","volume":"3","author":[{"given":"Bruce L","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas De","family":"Schryver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pccm.2025.02.003_bib0001","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.2024.10168","article-title":"Resolving the dilemma on continuous vs intermittent \u03b2-lactam antibiotics in sepsis","volume":"332","author":"Wiersinga","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.pccm.2025.02.003_bib0002","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/CM9.0000000000002237","article-title":"Identification of prophylaxis and treatment for hospitalized patients associated with venous thromboembolism","volume":"136","author":"Yang","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.pccm.2025.02.003_bib0003","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.3390\/jcm11174997","article-title":"Assessment of the effect on thromboprophylaxis with multifaceted quality improvement intervention based on clinical decision support system in hospitalized patients: a pilot study","volume":"11","author":"Gao","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.pccm.2025.02.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029024","article-title":"Revised definition of pulmonary hypertension and approach to management: a clinical primer","volume":"12","author":"Maron","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pccm.2025.02.003_bib0005","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1001\/jama.2021.19282","article-title":"Diagnostic strategies for suspected pulmonary embolism","volume":"326","author":"Levi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.pccm.2025.02.003_bib0006","article-title":"The role of the PERT team","volume":"6","author":"Saif","year":"2022","journal-title":"Thrombosis Upd"},{"key":"10.1016\/j.pccm.2025.02.003_bib0007","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.1997.00440430038005","article-title":"Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis","volume":"157","author":"Hull","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pccm.2025.02.003_bib0008","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-119-9-199311010-00002","article-title":"The weight-based heparin dosing nomogram compared with a \"standard care\" nomogram. A randomized controlled trial","volume":"119","author":"Raschke","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pccm.2025.02.003_bib0009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with Enoxaparin Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pccm.2025.02.003_bib0010","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.4081\/hr.2015.5844","article-title":"The anti-factor xa range for low molecular weight heparin thromboprophylaxis","volume":"7","author":"Wei","year":"2015","journal-title":"Hematol Rep"},{"key":"10.1016\/j.pccm.2025.02.003_bib0011","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/bjs.4068","article-title":"Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients","volume":"90","author":"Frederiksen","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.pccm.2025.02.003_bib0012","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/ajcp\/103.5.642","article-title":"Monitoring the anticoagulant effects of a low molecular weight heparin preparation. Correlation of assays in orthopedic surgery patients receiving ardeparin sodium for prophylaxis of deep venous thrombosis","volume":"103","author":"Kessler","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pccm.2025.02.003_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000502847","article-title":"Pharmacokinetic comparison of subcutaneous and intravenous nadroparin administration for thromboprophylaxis in critically ill patients on vasopressors","volume":"105","author":"Cihlar","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.pccm.2025.02.003_bib0014","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1055\/s-0037-1613090","article-title":"Dosing in heavy-weight\/obese patients with the LMWH, tinzaparin: a pharmacodynamic study","volume":"87","author":"Hainer","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pccm.2025.02.003_bib0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(02)07920-5","article-title":"Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors","volume":"359","author":"D\u00f6rffler-Melly","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pccm.2025.02.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154029","article-title":"Pharmacokinetic profiles of intravenous versus subcutaneous administration of low molecular weight heparin for thromboprophylaxis in critically ill patients: a randomized controlled trial","volume":"70","author":"De Schryver","year":"2022","journal-title":"J Crit Care"},{"key":"10.1016\/j.pccm.2025.02.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/tsaco-2020-000643","article-title":"Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document","volume":"6","author":"Rappold","year":"2021","journal-title":"Trauma Surg Acute Care Open"},{"key":"10.1016\/j.pccm.2025.02.003_bib0018","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TA.0000000000001142","article-title":"If some is good, more is better: an enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis","volume":"81","author":"Berndtson","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.pccm.2025.02.003_bib0019","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM199204093261502","article-title":"Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis","volume":"326","author":"Hull","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pccm.2025.02.003_bib0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199709043371002","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire","volume":"337","author":"Simonneau","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pccm.2025.02.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100185","article-title":"The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin","volume":"7","author":"Sytema","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.pccm.2025.02.003_bib0022","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.2023.9538","article-title":"Treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19-reply","volume":"330","author":"Goligher","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.pccm.2025.02.003_bib0023","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJM198310203091605","article-title":"Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement","volume":"309","author":"Leyvraz","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pccm.2025.02.003_bib0024","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.CIR.80.4.935","article-title":"Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study","volume":"80","author":"Albada","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.pccm.2025.02.003_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2017.08.014","article-title":"Plasma anti-FXa concentration after continuous intravenous infusion and subcutaneous dosing of enoxaparin for thromboprophylaxis in critically ill patients. A randomized clinical trial","volume":"158","author":"Vahtera","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.pccm.2025.02.003_bib0026","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2710.2005.00634.x","article-title":"Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety","volume":"30","author":"Kane-Gill","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.pccm.2025.02.003_bib0027","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MBC.0b013e32830b14de","article-title":"Continuous intravenous infusion of a low-molecular-weight heparin during allogenic haematopoietic stem-cell transplantation","volume":"19","author":"Boeras","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 2","key":"10.1016\/j.pccm.2025.02.003_bib0028","first-page":"30","article-title":"Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin","volume":"16","author":"Holm","year":"1986","journal-title":"Haemostasis"},{"key":"10.1016\/j.pccm.2025.02.003_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013406","article-title":"Outcomes in high-risk pulmonary embolism patients undergoing FlowTriever mechanical thrombectomy or other contemporary therapies: results from the FLAME study","volume":"16","author":"Silver","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pccm.2025.02.003_bib0030","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jcin.2021.04.049","article-title":"Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism: the SUNSET sPE trial","volume":"14","author":"Avgerinos","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pccm.2025.02.003_bib0031","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10654-015-0105-7","article-title":"The Rotterdam Scan Study: design update 2016 and main findings","volume":"30","author":"Ikram","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.pccm.2025.02.003_bib0032","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"Pengo","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pccm.2025.02.003_bib0033","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/eurheartj\/ehab816","volume":"43","author":"Klok","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Chinese Medical Journal Pulmonary and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772558825000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772558825000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T11:14:30Z","timestamp":1743506070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772558825000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2772558825000039"],"URL":"https:\/\/doi.org\/10.1016\/j.pccm.2025.02.003","relation":{},"ISSN":["2772-5588"],"issn-type":[{"value":"2772-5588","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary embolism prophylaxis and treatment: What's right, what's wrong, and the future","name":"articletitle","label":"Article Title"},{"value":"Chinese Medical Journal Pulmonary and Critical Care Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pccm.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}